347 results on '"Pancera, Marie"'
Search Results
2. Cross-protective antibodies against common endemic respiratory viruses
3. Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9
4. Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge
5. Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
6. Progress in the Development of Broadly Reactive Norovirus Therapeutics
7. Broadly inhibitory antibodies against severe malaria virulence proteins
8. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
9. Direct Blockade of the Norovirus Histo-Blood Group Antigen Binding Pocket by Nanobodies
10. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
11. Cryo-EM structures of anti-malarial antibody L9 with circumsporozoite protein reveal trimeric L9 association and complete 27-residue epitope
12. Structures of drug-specific monoclonal antibodies bound to opioids and nicotine reveal a common mode of binding
13. Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
14. Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9
15. Structural Biology and the Design of Effective Vaccines for HIV-1 and Other Viruses
16. Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
17. Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
18. Cross-Protective Antibodies Against Common Endemic Respiratory Viruses
19. Highly protective antimalarial antibodies via precision library generation and yeast display screening
20. Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
21. Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
22. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains
23. Germline‐targeting immunogens
24. Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface
25. Structure and immune recognition of trimeric pre-fusion HIV-1 Env
26. Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge
27. The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria
28. Structure of HIV-1 gp120 with gp41-Interactive Region Reveals Layered Envelope Architecture and Basis of Conformational Mobility
29. Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120
30. Vaccination in a humanized mouse model elicits highly protective PfCSP-targeting anti-malarial antibodies
31. Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization
32. Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
33. The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria
34. Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit
35. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects
36. Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies
37. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
38. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
39. Design of Alphavirus Virus-Like Particles Presenting Circumsporozoite Junctional Epitopes That Elicit Protection against Malaria
40. Multimeric antibodies from antigen-specific human IgM+ memory B cells restrict Plasmodium parasites
41. Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects
42. Protective antibodies against human parainfluenza virus type 3 infection
43. Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization
44. HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors
45. A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver
46. Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
47. A biosensor-based approach toward purification and crystallization of G protein-coupled receptors
48. Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
49. Protective Antibodies Against Human Parainfluenza Virus Type 3 (HPIV3) Infection
50. Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.